$Tonix Pharmaceuticals (TNXP.US)$ Looking back my old post, this is the very important month we are looking for. Mid of dec we will know. Considering that the company has one year to execute the reverse split (R/S) after shareholder approval, they can cancel it at any time before Oct29 2025. Expected Timeline and Possible Events: October 30, 2024:Seeking shareholder approval for the R/S. If shareholders approve, they can exercise this R/S decision before Oct29, 2025 (within one year). December 20...
$Tonix Pharmaceuticals (TNXP.US)$ This is a high-risk, high-reward bet that could turn 4 digits into 5 digits (or 5 digits into 6 digits) if approved between June and August 2025 without further dilution. It offers the opportunity for at least 4x returns or possibly up to 10x, but it could also result in a complete loss of your investment. This opportunity is only suitable for high-risk takers who have conducted thorough due diligence and are prepared to lose the money without regret. Invest only...
6
2
Report
Arrayfunction
:
Amazing post! It's awesome to see someone take the time to educate people about the nuisances of biotech. I also appreciate how you outlined the risk involved multiple times. This is great content. I've always wondered why retail investors don't come together on a platform like Stack Overflow so we can all learn from each other's unique insights. I think that was Peter Lynch's advice? Not sure, I don't know much about the history of fund managers
72638079
Arrayfunction
:
I agree, just started actively trading recently and find it hard to find a consolidated place of educated investors having open discussion. Can we start groups on here?
$Tonix Pharmaceuticals (TNXP.US)$mid Dec we should get the acceptance or decline by FDA, plus news on the recent appointments. Loaded some for 2nd round. Hopefully they get it to work and start growing! They has been failing over and over for years.
$Inovio Pharmaceuticals (INO.US)$Reuters· 1 min ago New Retrospective Data Shows Half of Rrp Patients Treated With Ino-3107 Achieved a Complete Response When Evaluated 2 and 3 Years Following Initial Phase 1/2 Trial
$Tonix Pharmaceuticals (TNXP.US)$On December 3, 2024, Tonix Pharmaceuticals announced the hiring of Bradley Raudabaugh as VP of Marketing and Errol Gould, Ph.D., as VP of Medical Affairs. This strategic expansion aims to support the launch of TNX-102 SL for fibromyalgia management.The company submitted a New Drug Application (NDA) for TNX-102 SL to the FDA in October 2024, with acceptance expected in December 2024. If approved, TNX-102 SL would be the first new fibromyalgia drug in over ...
Looking back my old post, this is the very important month we are looking for.
Mid of dec we will know.
Considering that the company has one year to execute the reverse split (R/S) after shareholder approval, they can cancel it at any time before Oct29 2025.
Expected Timeline and Possible Events:
October 30, 2024:Seeking shareholder approval for the R/S. If shareholders approve, they can exercise this R/S decision before Oct29, 2025 (within one year).
December 20...
This is a high-risk, high-reward bet that could turn 4 digits into 5 digits (or 5 digits into 6 digits) if approved between June and August 2025 without further dilution. It offers the opportunity for at least 4x returns or possibly up to 10x, but it could also result in a complete loss of your investment. This opportunity is only suitable for high-risk takers who have conducted thorough due diligence and are prepared to lose the money without regret. Invest only...
New Retrospective Data Shows Half of Rrp Patients Treated With Ino-3107 Achieved a Complete Response When Evaluated 2 and 3 Years Following Initial Phase 1/2 Trial
No comment yet